Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
Although only recently introduced in the ILD community, the concept of progressive fibrosing interstitial lung disease (PF-ILD) has rapidly acquired an important place in the management of non-idiopathic pulmonary fibrosis fibrosing ILD (nonIPF fILD) patients. It confirms a clinical gut feeling that...
Main Authors: | Laurens J. De Sadeleer, Tinne Goos, Jonas Yserbyt, Wim A. Wuyts |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/6/1722 |
Similar Items
-
Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
by: John N. Shumar, et al.
Published: (2021-05-01) -
Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be
by: Tinne Goos, et al.
Published: (2021-03-01) -
Biomarkers of Progressive Fibrosing Interstitial Lung Diseases
by: E. V. Bolotova, et al.
Published: (2023-11-01) -
Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study
by: Kyung-In Joung, et al.
Published: (2023-03-01) -
Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
by: Julien Guiot, et al.
Published: (2023-09-01)